LYNDA MAXFIELD: Open Payments
NPI 1932654753 · CLIO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 29 payments from 16 companies in 2025. Trend: 2023 $649 · 2024 $957 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $143 |
| Vanda Pharmaceuticals Inc. | 5 | $139 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Alkermes, Inc. | 2 | $61 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Exact Sciences Corporation | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $30 |
| Indivior Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $21 |
Products named: CAPLYTA, FANAPT, REXULTI, Auvelity, AUSTEDO XR, VIVITROL, ARISTADA, The Cologuard Plus Collection Kit.
Industry payments across MI — which companies pay providers there.
